Opportunity Information: Apply for RFA AG 23 017

The Claude D. Pepper Older Americans Independence Centers (OAIC) program (RFA-AG-23-017) is a National Institutes of Health funding opportunity that supports the creation or strengthening of specialized research centers focused on aging and geriatrics. The core purpose is to build centers of excellence that advance both research and research education aimed at helping older adults maintain or regain independence. In practical terms, the program is meant to concentrate expertise, infrastructure, and training in a way that accelerates scientific progress on problems that commonly threaten independent living in later life, such as functional decline, mobility limitations, frailty, disability, and other age-related conditions that reduce day-to-day autonomy.

This FOA uses the P30 center grant mechanism, which typically emphasizes shared resources, coordinated programs, and a unifying theme rather than a single stand-alone research project. Applicants are expected to propose a clear, well-defined aging research focus area aligned with the OAIC mission, and to show how the center will sustain momentum and measurable progress in that area over time. The announcement also notes that clinical trials are optional, meaning the center can include clinical trial activity if it fits the scientific goals, but it is not required to do so. Overall, the emphasis is on building durable capacity in geriatrics research and training, producing tools, methods, evidence, and interventions that can translate into better strategies to preserve or restore functional independence for older people.

The opportunity is categorized as a discretionary grant in the health funding area (CFDA 93.866) and is administered by NIH. The listed award ceiling is $925,000. While the expected number of awards is not specified in the provided details, the structure of the program indicates competitive selection of a limited number of center awards designed to have strong institutional commitment and a significant impact on the field.

Eligibility is broad across U.S.-based organizational types and includes many government and non-government applicants. Eligible entities include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and additional applicants captured under an "others" category. The FOA also explicitly highlights additional eligible applicant groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This framing signals an intent to encourage broad participation and to strengthen geriatrics research capacity across a wide range of institutional settings.

At the same time, there are clear limits related to foreign participation. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as the primary applicant. However, "foreign components" as defined by NIH policy are allowed, which generally means a U.S. applicant organization may include certain approved international collaborations or elements when they are justified scientifically and compliant with NIH Grants Policy Statement requirements.

Key administrative details provided include an original closing date of October 19, 2022, and a creation date of July 5, 2022. The funding instrument type is a grant, and the activity category is health. In summary, this OAIC FOA is designed for institutions that can anchor a coordinated geriatrics research center with a strong thematic focus, shared infrastructure, and a clear plan to advance research and research training that leads directly to improved independence outcomes for older adults.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-07-05.
  • Applicants must submit their applications by 2022-10-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $925,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 23 017

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: F23AS00080 - Highlands Conservation Act Grant Program – Capacity Building Cooperative Agreement

Previous opportunity: Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 23 017

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 23 017) also looked into and applied for these:

Funding Opportunity
Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) Apply for PAR 22 211

Funding Number: PAR 22 211
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 23 029

Funding Number: RFA AG 23 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,838,436
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Apply for PAR 22 170

Funding Number: PAR 22 170
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 23 030

Funding Number: RFA AG 23 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,838,436
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed) Apply for RFA HL 23 015

Funding Number: RFA HL 23 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $373,000
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 22 213

Funding Number: PAR 22 213
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA HL 23 016

Funding Number: RFA HL 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 22 169

Funding Number: PAR 22 169
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) Apply for RFA AG 23 021

Funding Number: RFA AG 23 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,800,000
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) Apply for RFA MH 22 281

Funding Number: RFA MH 22 281
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 280

Funding Number: RFA MH 22 280
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 22 193

Funding Number: PAR 22 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 22 192

Funding Number: PAR 22 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 22 189

Funding Number: PAR 22 189
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 22 029

Funding Number: RFA TR 22 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $325,000
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) Apply for PAR 22 190

Funding Number: PAR 22 190
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Apply for PAR 22 191

Funding Number: PAR 22 191
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) Apply for PAR 22 212

Funding Number: PAR 22 212
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 046

Funding Number: RFA AI 22 046
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed) Apply for RFA AA 22 003

Funding Number: RFA AA 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 017", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: